Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Dec 2:9:195.
doi: 10.1186/1471-2334-9-195.

High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial

Beatrice Amadi  1 , Mwiya Mwiya, Sandie Sianongo, Lara Payne, Angela Watuka, Max Katubulushi, Paul Kelly
Affiliations
Randomized Controlled Trial

High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial

Beatrice Amadi et al. BMC Infect Dis. .

Abstract

Background: Treatment of cryptosporidiosis in HIV infected children has proved difficult and unsatisfactory with no drugs having demonstrable efficacy in controlled trials except nitazoxanide. We hypothesised that a prolonged course of treatment with high dose nitazoxanide would be effective in treating cryptosporidiosis in HIV positive Zambian children.

Methods: We performed a double-blind, randomised, placebo controlled trial in paediatric patients in the UTH in Lusaka. The study included HIV positive children between one and eleven years of age if 2 out of 3 stool samples were positive for oocysts of Cryptosporidium spp. Children were given nitazoxanide suspension in a dose of 200 mg twice daily (bid) for 28 days (if 1-3 years old) or 400 mg bid for 28 days (if 4-11 years old), or matching placebo.

Results: Sixty children were randomised and 52 were fully evaluated. Only five children were 4 years of age or over and received the higher dose. In the primary efficacy analysis, 11 out of 26 (42%) in the active treatment group achieved a 'Well' clinical response compared to 8 out of 26 (35%) in the placebo group. Parasitological response was declared as 'Eradicated' in 27% in the active group and 35% in the placebo group. Mortality (16/52, 31%) did not differ by treatment allocation.

Conclusion: We found no significant benefit in children with cryptosporidiosis despite high dose and longer treatment duration. This is the second randomised controlled trial to suggest that in Zambian children with HIV-related immunosuppression nitazoxanide does not eradicate this infection nor provide clinical symptom reduction.

Trial registration: The trial was registered as ISRCTN41089957.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of participants through the trial.
See this image and copyright information in PMC

References

    1. Mølbak K, Andersen M, Aaby P, Højlyng N, Jakobsen M, Sodemann M, da Silva AP. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, West Africa. Am J Clin Nutr. 1997;65:149–52. - PubMed
    1. Amadi BC, Kelly P, Mwiya M, Mulwazi E, Sianongo S, Changwe F, Thomson M, Hachungula J, Watuka A, Walker-Smith JA, Chintu C. Intestinal and systemic infection, HIV and mortality in Zambian children with persistent diarrhoea and malnutrition. J Ped Gast Nutr. 2001;32:550–554. doi: 10.1097/00005176-200105000-00011. - DOI - PubMed
    1. Nchito M, Kelly P, Sianongo S, Luo NP, Feldman RA, Farthing MJG, Baboo KS. Cryptosporidiosis in urban Zambian children: an analysis of risk factors. Am J Trop Hyg. 1998;59:435–437. - PubMed
    1. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhoea and cryptosporidiosis with impaired physical fitness and cognitive function 4-7 years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg. 1999;61:707–13. - PubMed
    1. White AC. Nitazoxanide: an important advance in anti-parasitic therapy. Am J Trop Med Hyg. 2003;68:382–3. - PubMed

Publication types

Associated data